Healthcare - Biotechnology - NASDAQ - US
$ 5.105
-8.84 %
$ 854 M
Market Cap
-2.03
P/E
Price Target
Average
265.65%
Revenue Forecast
Estimate
55.27%
EBIT
Estimate
32.07%
Net Income
Estimate
12.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Relay Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for RLAY of $18.7 , with forecasts ranging from a low of $15 to a high of $25 .
RLAY Lowest Price Target
Wall Street Target
15 USD
193.83%
RLAY Average Price Target
Wall Street Target
18.7 USD
265.65%
RLAY Highest Price Target
Wall Street Target
25 USD
389.72%
REVENUE FORECAST
Revenue Forecast Chart RLAY
EBIT FORECAST
EBIT Forecast Chart RLAY
NET INCOME FORECAST
Net Income Chart RLAY